Digest Network Come funziona
Network
/
Società
Ro
Non verificato

Rocket Pharmaceuticals, Inc.

Di cosa scriviamo

BiotecnologiaCardiologiaFarmaceuticaMedicina - VarieSalute

35 comunicati stampa

Guarda tutti i comunicati
28/05/2026
Salute
Sanità
Scienza
Farmaceutica
Cardiologia
Biotecnologia
Eventi
Web e Social Network
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
Fonte
Rocket Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
07/05/2026
Mercato azionario
Industria
Web e Social Network
Telefonia e Varie
Salute
Biotecnologia
Medicina - Varie
Farmaceutica
Cardiologia
Rocket Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Recent Progress
Fonte
Rocket Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
28/04/2026
Scienza
Cardiologia
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Rocket Pharmaceuticals Announces $180 Million Sale of Priority Review Voucher
Fonte
Rocket Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
27/03/2026
Telefonia e Varie
Industria
Igiene alimentare
Salute
Biotecnologia
Medicina - Varie
Farmaceutica
Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)
Fonte
Rocket Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
26/02/2026
Mercato azionario
Salute
Biotecnologia
Medicina - Varie
Farmaceutica
Cardiologia
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress
Fonte
Rocket Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
23/02/2026
Eventi
Web e Social Network
Oncologia
Salute
Biotecnologia
Sanità
Farmaceutica
Cardiologia
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
Fonte
Rocket Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
05/01/2026
Eventi
Salute
Biotecnologia
Scienza
Farmaceutica
Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Fonte
Rocket Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
25/11/2025
Eventi
Web e Social Network
Salute
Biotecnologia
Medicina - Varie
Farmaceutica
Cardiologia
Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference
Fonte
Rocket Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
06/11/2025
Mercato azionario
Biotecnologia
Igiene alimentare
Salute
Farmaceutica
Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
Fonte
Rocket Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
14/10/2025
Oncologia
Salute
Igiene alimentare
Sanità
Medicina - Varie
Farmaceutica
Biotecnologia
Industria
Rocket Pharmaceuticals Announces FDA Acceptance of BLA Resubmission of KRESLADI™ for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I)
Fonte
Rocket Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0